Barclays Increases Kimberly-Clark (NYSE:KMB) Price Target to $144.00

Kimberly-Clark (NYSE:KMB) had its price target hoisted by research analysts at Barclays from $135.00 to $144.00 in a report released on Friday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Barclays‘s price target would indicate a potential upside of 1.23% from the company’s current price.

KMB has been the topic of several other research reports. Piper Sandler raised their target price on shares of Kimberly-Clark from $167.00 to $174.00 and gave the company an “overweight” rating in a research note on Thursday, July 11th. JPMorgan Chase & Co. raised their price objective on shares of Kimberly-Clark from $137.00 to $142.00 and gave the company an “underweight” rating in a research note on Friday. TD Cowen assumed coverage on Kimberly-Clark in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $161.00 target price for the company. Wells Fargo & Company lowered their price target on Kimberly-Clark from $138.00 to $134.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 24th. Finally, StockNews.com lowered Kimberly-Clark from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 30th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, Kimberly-Clark presently has a consensus rating of “Hold” and an average price target of $149.14.

Kimberly-Clark Price Performance

NYSE KMB opened at $142.25 on Friday. The company has a 50-day moving average price of $142.59 and a two-hundred day moving average price of $137.79. The stock has a market cap of $47.91 billion, a price-to-earnings ratio of 21.07, a price-to-earnings-growth ratio of 2.98 and a beta of 0.39. The company has a current ratio of 0.85, a quick ratio of 0.58 and a debt-to-equity ratio of 5.59. Kimberly-Clark has a 52 week low of $116.63 and a 52 week high of $149.30.

Kimberly-Clark (NYSE:KMB) last posted its earnings results on Tuesday, July 23rd. The company reported $1.96 EPS for the quarter, beating the consensus estimate of $1.71 by $0.25. Kimberly-Clark had a return on equity of 223.55% and a net margin of 11.28%. The firm had revenue of $5.03 billion for the quarter, compared to analysts’ expectations of $5.10 billion. During the same period last year, the firm earned $1.65 EPS. The firm’s revenue was down 2.0% compared to the same quarter last year. Analysts forecast that Kimberly-Clark will post 7.25 EPS for the current year.

Insider Activity

In related news, insider Gonzalo Uribe sold 1,780 shares of the company’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $140.84, for a total transaction of $250,695.20. Following the transaction, the insider now directly owns 7,377 shares of the company’s stock, valued at approximately $1,038,976.68. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Kimberly-Clark news, insider Jeffrey P. Melucci sold 37,699 shares of Kimberly-Clark stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $141.42, for a total transaction of $5,331,392.58. Following the completion of the sale, the insider now owns 19,935 shares of the company’s stock, valued at $2,819,207.70. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Gonzalo Uribe sold 1,780 shares of the company’s stock in a transaction on Monday, July 29th. The stock was sold at an average price of $140.84, for a total transaction of $250,695.20. Following the completion of the transaction, the insider now directly owns 7,377 shares in the company, valued at $1,038,976.68. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.62% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. William B. Walkup & Associates Inc. bought a new stake in shares of Kimberly-Clark in the 2nd quarter valued at approximately $26,000. Rise Advisors LLC grew its position in Kimberly-Clark by 926.3% in the first quarter. Rise Advisors LLC now owns 195 shares of the company’s stock worth $25,000 after acquiring an additional 176 shares in the last quarter. New Millennium Group LLC acquired a new position in shares of Kimberly-Clark during the 2nd quarter worth $28,000. Crewe Advisors LLC bought a new position in shares of Kimberly-Clark during the 1st quarter valued at $27,000. Finally, ORG Wealth Partners LLC acquired a new stake in shares of Kimberly-Clark in the 3rd quarter valued at $39,000. Hedge funds and other institutional investors own 76.29% of the company’s stock.

About Kimberly-Clark

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company’s Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.